Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis

被引:16
作者
Naunton, M
Peterson, GM
Jones, G
机构
[1] Univ Tasmania, Tasmanian Sch Pharm, Fac Hlth Sci, Hobart, Tas 7001, Australia
[2] Univ Tasmania, Menzies Res Inst, Fac Hlth Sci, Hobart, Tas 7001, Australia
关键词
community pharmacy; osteoporosis screening;
D O I
10.1345/aph.1G208
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
BACKGROUND: Osteoporosis is underdiagnosed, and rural communities often have limited technical resources for the assessment of osteoporosis. OBJECTIVE: To evaluate the impact of a pharmacist, trained in the use of a portable heel ultrasound device, in screening elderly rural women for risk of osteoporosis and determine whether those found to be at risk seek further help and treatment from their general practitioner (GP) following screening. METHODS: Following promotion of the service, 345 women were recruited from 6 rural community pharmacies in Tasmania, Australia, and underwent quantitative heel ultrasound screening. Women were comprehensively educated on risk factors for osteoporosis and completed a calcium intake questionnaire. Results were forwarded to each woman's GP, and the participants were followed up 3 months later to assess outcomes from the screening procedure. RESULTS: Approximately 20% of women were shown to be at high risk for osteoporosis; 201 (58%) of these were referred to their GP for further assessment. Sixty-eight percent of women who were screened discussed their results with their GP, and 11% underwent further investigation. Over one-third of women screened began medication (30% calcium, 6% bisphosphonate, 6% vitamin D) for osteoporosis. CONCLUSIONS: Pharmacist-provided screening for osteoporosis in rural areas is a potentially useful method to identify women at risk for fracture and a convenient time point for discussion of preventive therapy.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 25 条
[1]
*ACC EC PTY, 2001, BURD BRITTL BON COST, P1
[2]
Ahrens Renee A, 2003, J Am Pharm Assoc (2003), V43, P583
[3]
Women's knowledge of osteoporosis [J].
Ailinger, RL ;
Emerson, J .
APPLIED NURSING RESEARCH, 1998, 11 (03) :111-114
[4]
ANGUS RM, 1989, J AM DIET ASSOC, V89, P209
[5]
Diagnosis and management of osteoporosis: Guidelines for the utilization of bone densitometry [J].
Baran, DT ;
Faulkner, KG ;
Genant, HK ;
Miller, PD ;
Pacifici, R .
CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (06) :433-440
[6]
Physician treatment of osteoporosis in response to heel ultrasound bone mineral density reports [J].
Boyd, JL ;
Holcomb, JP ;
Rothenberg, RJ .
JOURNAL OF CLINICAL DENSITOMETRY, 2002, 5 (04) :375-381
[7]
Are rural residents less likely to obtain recommended preventive healthcare services? [J].
Casey, MM ;
Call, KT ;
Klingner, JM .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2001, 21 (03) :182-188
[8]
Cerulli Jennifer, 2004, J Am Pharm Assoc (2003), V44, P161, DOI 10.1331/154434504773062618
[9]
Epidemiology and outcomes of osteoporotic fractures [J].
Cummings, SR ;
Melton, LJ .
LANCET, 2002, 359 (9319) :1761-1767
[10]
Pharmacy-based bone mass measurement to assess osteoporosis risk [J].
Elliott, ME ;
Meek, PD ;
Kanous, NL ;
Schill, GR ;
Weinswig, PA ;
Bohlman, JP ;
Zimpel, CL ;
Jensen, BC ;
Walters, DR ;
Sutter, SL ;
Peterson, AN ;
Peterson, RM ;
Binkley, NC .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (04) :571-577